SCHEMBL7969453

SCHEMBL7969453

CCCCC(=O)Nc1oc(-c2cccc(-c3ccc(-c4ccc5ccccc5c4)cc3)c2O)nc1-c1cccnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.46
KDM4E B2RXH2 6/20 0.46
ALDH1A1 P00352 6/20 0.46
HSD17B10 Q99714 5/20 0.46
GLA P06280 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.44
KDR P35968 6/20 0.42
FLT1 P17948 1/20 0.42
FLT4 P35916 1/20 0.42
ABL1 P00519 2/20 0.40
PDGFRB P09619 1/20 0.40
SRC P12931 1/20 0.40
PDGFRA P16234 1/20 0.40
PRKCA P17252 1/20 0.40
PRKCD Q05655 1/20 0.40
POLB P06746 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.40
BCR P11274 1/20 0.40
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7981666 0.89 KDR (0.46) HPGDKDM4EALDH1A1HSD17B10GLA
SCHEMBL7982616 0.87 KDR (0.56) RAB9AKDRFLT1FLT4ABL1
SCHEMBL7744651 0.86 HPGD (0.51) HPGDKDM4EALDH1A1HSD17B10GLA
SCHEMBL7980265 0.84 SIRT2 (0.52) ALDH1A1RAB9ASMN1; SMN2KDRFLT1
SCHEMBL7744655 0.83 HPGD (0.50) HPGDKDM4EALDH1A1HSD17B10GLA
SCHEMBL7981663 0.82 KDR (0.50) HPGDKDM4EALDH1A1HSD17B10GLA
SCHEMBL7744758 0.78 ALDH1A1 (0.46) HPGDKDM4EALDH1A1HSD17B10GLA
SCHEMBL7739022 0.77 KDR (0.54) HPGDKDM4EALDH1A1HSD17B10RAB9A
SCHEMBL7744763 0.77 KDM4E (0.46) HPGDKDM4EALDH1A1HSD17B10GLA
SCHEMBL7979621 0.75 KDR (0.50) KDM4EALDH1A1RAB9ASMN1; SMN2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed